Similar articles

• Occurrence of antipseudomonal beta-lactams and aminoglycosides resistance in Pseudomonas aeruginosa during therapy.

  Pagani L, Scarabelli M, Cereda PM, Debiaggi M. Pagani L, et al. Microbiologica. 1987 Jan;10(1):103-10. Microbiologica. 1987. PMID: 3106759
• Efficacy of antimicrobial drug combinations against Pseudomonas aeruginosa: beta-lactams and aminoglycosides.

  Martinetto P, Malcangi A, Penna R. Martinetto P, et al. G Ital Chemioter. 1988 Jan-Dec;35(1-3):17-21. G Ital Chemioter. 1988. PMID: 3151486 No abstract available.
• Synergistic in vitro and in vivo activities of ampicillin and aminoglycoside combinations against antibiotic-resistant Pseudomonas aeruginosa strains.

  Elkhouly AE, el-Sokkary MA, el-Emam MA. Elkhouly AE, et al. Chemioterapia. 1987 Jun;6(2 Suppl):125-8. Chemioterapia. 1987. PMID: 3151331 No abstract available.
• [Mechanisms of resistance in Pseudomonas aeruginosa].

  Cercenado Mansilla E, García Garrote F. Cercenado Mansilla E, et al. Rev Clin Esp. 1998 Sep;198 Suppl 2:10-6. Rev Clin Esp. 1998. PMID: 9844472 Review. Spanish. No abstract available.
• Antimicrobials in cystic fibrosis: emergence of resistance and implications for treatment.

  Zabner R, Quinn JP. Zabner R, et al. Semin Respir Infect. 1992 Sep;7(3):210-7. Semin Respir Infect. 1992. PMID: 1475544 Review.